| PACKAGING TYPE: | 10x1x5 Blister (10 Monocarton In 1 Box) |
| COMPOSITION: | Letrozole 2.5mg Tablet |
| FORMULATION: | Tablet |
| Description: | BREASTOZ 2.5 Tablet contains Letrozole 2.5mg, a non-steroidal aromatase inhibitor used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Letrozole works by inhibiting the aromatase enzyme, which reduces the production of estrogen in the body. Since certain breast cancers grow in response to estrogen, lowering estrogen levels helps slow or stop the growth of cancer cells. It is also used in ovulation induction in infertility treatment under medical supervision. |
| Side Effects: | Common side effects: Hot flashes Fatigue Joint pain (arthralgia) Nausea Rare but serious side effects: Bone thinning (osteoporosis) Increased cholesterol levels Cardiovascular risks Allergic reactions (rash, swelling) |
| How to Use: | Take BREASTOZ 2.5 Tablet orally, as prescribed by a healthcare professional. Usually taken once daily. Swallow with water; can be taken with or without food. Follow the prescribed duration strictly. |
| Precaution: | Not recommended in premenopausal women unless advised. Monitor bone density and cholesterol levels during long-term use. Avoid use during pregnancy and breastfeeding. Inform your doctor about other medications. Use cautiously in patients with liver disorders. |
| Product Benefits: | Effective in treating hormone-dependent breast cancer. Helps reduce tumor growth and recurrence risk. Used in adjuvant and advanced breast cancer therapy. May be used for ovulation induction in infertility. Suitable for long-term therapy under medical |
Frequently Asked Questions
It is used for breast cancer treatment and ovulation induction.
It reduces estrogen production, which helps slow cancer growth.
Yes, long-term use may lead to bone thinning (osteoporosis).










